Atrial Fibrillation
Wednesday, April 2nd, 2014
AHA – CIRCEP: March 8, 2014 Background—Endogenous sex hormones have been related to cardiovascular outcomes and mortality. We hypothesized that sex hormones are related to atrial fibrillation (AF) in a community-based cohort of middle-aged to older men. Methods and Results—We examined testosterone, estradiol, and dehydroepiandrosterone sulfate [DHEA-S]) in relation to incident AF in men participating in […]
Atrial Fibrillation
Wednesday, April 2nd, 2014
CIRCULATIONAHA: 3/4/14 Atrial fibrillation (AF) is the most common sustained heart rhythm disorder, with an estimated prevalence of 0.4% to 1% in the general population. In addition, AF is responsible for approximately 15% to 20% of ischemic strokes. Device interventions to prevent strokes in patients with AF are nonsurgical procedures to block blood clots (thrombus) from […]
Atrial Fibrillation
Wednesday, April 2nd, 2014
J Am Heart Assoc.: January 21, 2014 New‐Onset Atrial Fibrillation is Associated With Cardiovascular Events Leading to Death in a First Time Myocardial Infarction Population of 89 703 Patients With Long‐Term Follow‐Up: A Nationwide Study Background New‐onset atrial fibrillation (AF) is reported to increase the risk of death in myocardial infarction (MI) patients. However, previous studies have […]
Atrial Fibrillation
Sunday, March 2nd, 2014
BMC Health Services Research: February 20, 2014 Background Atrial fibrillation (AF) and heart failure (HF) are both common comorbid conditions of elderly patients with acute coronary syndrome (ACS), but published data on their associated clinical and economic outcomes are limited. Methods Our study included patients from the Medicare Current Beneficiary Survey with an incident hospitalization for […]
Atrial Fibrillation
Sunday, March 2nd, 2014
PLOS: February 11, 2014 Background Patients with atrial fibrillation considering use of anticoagulants must balance stroke reduction against bleeding risk. Knowledge of bleeding risk without the use of anticoagulants may help inform this decision. Purpose To determine the rate of major bleeding reported in observational studies of atrial fibrillation patients not receiving Vitamin K antagonists […]
Atrial Fibrillation
Sunday, March 2nd, 2014
JACC: February 2014 The historical origin of the term ‘lone atrial fibrillation (AF)’ predates by 80 years our current understanding of the pathophysiology of AF, the multitude of known etiologies for AF, and our ability to image and diagnose heart disease. The term was meant to indicate AF in whom subsequent investigations could not demonstrate […]
Atrial Fibrillation
Sunday, March 2nd, 2014
Circulation: Arrhythmia and Electrophysiology.: January 20, 2014 Background—Inflammation has been linked to the genesis of stroke in atrial fibrillation (AF) and is implicated in early recurrent arrhythmia after AF ablation. We aimed to define the time course of inflammation, myocardial injury, and prothrombotic markers after radiofrequency ablation for AF and its relation to AF recurrence. Methods […]
Atrial Fibrillation
Sunday, March 2nd, 2014
STROKEAHA: January 14, 2014 Background and Purpose—Supraventricular premature beats (SPBs) may help to assess the risk of atrial fibrillation (AF) in patients with cryptogenic stroke and therefore guide therapy. Methods—An internal loop recorder was implanted in consecutive patients with acute cryptogenic stroke. The occurrence and quantity of SPBs and short supraventricular runs (SVRs) in 24-hour ECG […]
Atrial Fibrillation
Wednesday, February 26th, 2014
JAMA: February 17, 2014 Concerns have been expressed about the reliability of clinical practice guidelines. We analyzed 3 guidelines from medical specialty societies about dronedarone hydrochloride, an antiarrhythmic drug related to amiodarone hydrochloride, for treatment of patients with atrial fibrillation. We compared the recommendations in these guidelines with the conclusions about dronedarone that we reached by applying […]
Atrial Fibrillation
Wednesday, February 26th, 2014
CIRCEP: February 11, 2014 Background—Cardiac tamponade is the most dramatic complication observed during atrial fibrillation (AF) ablation and the leading cause of procedure-related mortality. Female gender is a known risk factor for complications during AF ablation; however, it is unknown whether women have a higher risk of tamponade. Methods and Results—A systematic Medline search was used […]
